semaglutide clayton nc Medical Weight Loss GLP-1 in North Carolina (NC) Novo Nordisk Plans $4.1B Fill-Finish

Investors are increasingly valuing Lilly as a platform company capable of dominating a multi-hundred-billion-dollar global obesity market

Foundayo (Orforglipron) Foundayo offers the latest choice in GLP-1 medication as a flexible, once-daily pill free from timing or food restrictions, approved in April 2026

We've recorded episodes for The SIBO Doctor Podcast for the last four years, so it felt a bit weird to be off the air, but needed it just to rejuvenate and get some of the creative juices flowing

Higher doses often yield stronger efficacy but also greater gastrointestinal issues, tolerability drop-outs, etc

Some users experience persistent but manageable side effects that continue throughout their treatment journey

The two also differ greatly in the role of System Xc : In ferroptosis, the inhibition of System Xc reduces cystine intake, leading to GSH depletion and GPX4 inactivation, and ultimately causing lipid damage